The market's opinion of the business has improved over the past five years, reflecting a track record of earnings growth. The company's strategy appears to be drawing new investors, with an average annual return of 10% over five years.
Gainers: •$Checkmate Pharmaceuticals(CMPI.US)$+331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash) •$Axsome Therapeutics(AXSM.US)$+27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder) •$超微電腦(SMCI.US)$+14.3% (earnings report) •$普拉格能源(PLUG.US)$+9.24% (t...
F.N.B. Corp股票討論區
專欄Today's pre-market stock movers: TSLA, T, NOK, UAL and more
In reaction to earnings/guidance:
• $超微電腦(SMCI.US)$ +18%,$諾基亞(NOK.US)$ +7.7%,$丹納赫(DHR.US)$ +6.3%,$RLI保險(RLI.US)$ +5%,$CSX運輸(CSX.US)$ +4.3%,$金沙集團(LVS.US)$ +4.2%,$美國鋁業公司(AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics(STLD.US)$ +2.8%,$Herc Holdings(HRI.US)$ +2.6%,$特斯拉(TSLA.US)$ +2.5%, $菲利普莫里斯(PM.US)$ +2.5%,$F.N.B. Corp(FNB.US)$ ...
專欄Today's pre-market stock movers: PLUG, CMPI, JNJ, LMT and more
• $Checkmate Pharmaceuticals(CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $超微電腦(SMCI.US)$ +14.3% (earnings report)
• $普拉格能源(PLUG.US)$ +9.24% (t...
暫無評論